CN1259360A - Medicine for treating pulmonary hart diseases - Google Patents

Medicine for treating pulmonary hart diseases Download PDF

Info

Publication number
CN1259360A
CN1259360A CN98123782A CN98123782A CN1259360A CN 1259360 A CN1259360 A CN 1259360A CN 98123782 A CN98123782 A CN 98123782A CN 98123782 A CN98123782 A CN 98123782A CN 1259360 A CN1259360 A CN 1259360A
Authority
CN
China
Prior art keywords
medicine
radix
herba
root
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN98123782A
Other languages
Chinese (zh)
Other versions
CN1123354C (en
Inventor
何天有
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98123782A priority Critical patent/CN1123354C/en
Publication of CN1259360A publication Critical patent/CN1259360A/en
Application granted granted Critical
Publication of CN1123354C publication Critical patent/CN1123354C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

A traditional Chinese prescription medicine is made from pilose asiabell root, astragalus root, poria, schisandra fruit, ephedra, ramulus cinnamomi, perilla seed, asarum herb, Chinese angelica root, herba lycopi, pinellia tuber, cortex acanthopanacis radicis, licorice, lumbricus etc through conventional prepn method. Said medicine possesses the functions of benefiting vital energy and promoting blood circulation, strengthening heart and benefiting lung, stopping cough and relieving phlegm, calming asthma etc.

Description

A kind of medicine for the treatment of pulmonary heart disease
The present invention relates to a kind of medicine for the treatment of pulmonary heart disease, specifically is the herbal mixture lung heart health of feedstock production with the Chinese herbal medicine.
Chronic pulmonary heart disease (Chronjccorpdlmondle) is called for short pulmonary heart disease, is a kind of commonly encountered diseases, frequently-occurring disease and difficult and complicated illness.In recent years, this sick sickness rate is in rising trend, and is particularly very big to healthy elder harm.At present, to the treatment of pulmonary heart disease, modern medicine is from heart tonifying, diuresis, infection or symptomatic treatment, can only mitigation symptoms, be difficult to cure, and also there is not the reliable medicine of an ideal Therapeutic Method of cover and the disease of specially effecting a permanent cure.Motherland's medical science from differential diagnosis of diseases with distinguish disease combining, use differentiation of symptoms and signs for classification of syndrome with in many ways, compound recipe carries out clinical observation research, obtains certain curative effect, but also do not succeed in developing reliable, the stable pure Chinese medicinal preparation of a kind of curative effect, meet clinical needs.
The heart failure, disturbance of blood circulation, water liquid Metabolic disorder, the pulmonary infection that the objective of the invention is to from pulmonary heart disease are started with, select for use have heart tonifying, the Chinese medicine of blood circulation promoting and blood stasis dispelling, relieving cough and asthma, inducing diuresis to remove edema forms effective preparation, thereby reaches the curative effect for the treatment of both the principal and secondary aspects of a disease.
Solution of the present invention, be based on understanding and the Therapeutic Principle of motherland's medical science to pulmonary heart disease, use the experience of tcm treatment according to syndrome differentiation, screening is sent as an envoy to its Chinese herbal medicine of effect with benefiting QI for activating blood circulation, heart tonifying lung benefiting, relieving cough and resolving phlegm, the diuretic of relievining asthma by the theory of Chinese medical science prescription, skim the cream off milk, according to a conventional method preparation.
Among the present invention, the percentage by weight of each raw material of Chinese medicine is:
Radix Codonopsis 10-25% Radix Astragali 10-25% Poria 5-15% Fructus Schisandrae Chinensis 5-15%
Herba Ephedrae 4-8% Ramulus Cinnamomi 4-8% Fructus Perillae 4-8% Herba Asari 2-5%
Rhizoma Pinelliae 4-8% Radix Angelicae Sinensis 4-8% Herba Lycopi 4-8% periploca sepium 2-5%
Radix Glycyrrhizae 2-5% Pheretima 4-8%.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, compatibility uniqueness of the present invention has the effect of benefiting QI for activating blood circulation, the sharp lung of heart tonifying, relieving cough and asthma, inducing diuresis to remove edema; Through clinical 180 routine observation of curative effect, wherein to cure 58 examples and account for 32%, 108 examples that are clearly better account for 60%, and invalid 14 examples account for 8%, and total effective rate is 92%.
2, intoxicating phenomenon does not take place in the present invention after mice lavage surpasses safe dose, thereby the present invention has no side effect, and is safe and effective.
3, preparation of the present invention can be suitable for preventing and treating chronic tracheitis, pulmonary heart disease and disease such as nervously breathing hard of causing, cough and asthma, abundant expectoration, cyanosis, edema.
Embodiments of the invention are:
Embodiment one:
A kind of medicine for the treatment of pulmonary heart disease is by the raw material of Chinese medicine of the following weight percent medicament made of formulation method routinely: Radix Codonopsis 19%, the Radix Astragali 19%, Poria 10%, Fructus Schisandrae Chinensis 10%, Herba Ephedrae 5%, Ramulus Cinnamomi 5%, Fructus Perillae 5%, Herba Asari 2%, the Rhizoma Pinelliae 5%, Radix Angelicae Sinensis 5%, Herba Lycopi 6%, periploca sepium 2%, Radix Glycyrrhizae 2%, Pheretima 5%.
Embodiment two:
A kind of medicine for the treatment of pulmonary heart disease is by the raw material of Chinese medicine of the following weight percent medicament made of formulation method routinely: Radix Codonopsis 10%, the Radix Astragali 18%, Poria 6%, Fructus Schisandrae Chinensis 12%, Herba Ephedrae 7%, Ramulus Cinnamomi 7%, Fructus Perillae 7%, Herba Asari 4%, the Rhizoma Pinelliae 7%, Radix Angelicae Sinensis 7%, Herba Lycopi 7%, periploca sepium 4%, Radix Glycyrrhizae 4%, Pheretima 7%.

Claims (1)

1, a kind of medicine for the treatment of pulmonary heart disease is characterized in that it is by the raw material of Chinese medicine of the following weight percent medicament made of formulation method routinely:
Radix Codonopsis 10-25% Radix Astragali 10-25% Poria 5-15% Fructus Schisandrae Chinensis 5-15%
Herba Ephedrae 4-8% Ramulus Cinnamomi 4-8% Fructus Perillae 4-8% Herba Asari 2-5%
Rhizoma Pinelliae 4-8% Radix Angelicae Sinensis 4-8% Herba Lycopi 4-8% periploca sepium 2-5%
Radix Glycyrrhizae 2-5% Pheretima 4-8%.
CN98123782A 1998-10-29 1998-10-29 Medicine for treating pulmonary hart diseases Expired - Fee Related CN1123354C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98123782A CN1123354C (en) 1998-10-29 1998-10-29 Medicine for treating pulmonary hart diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98123782A CN1123354C (en) 1998-10-29 1998-10-29 Medicine for treating pulmonary hart diseases

Publications (2)

Publication Number Publication Date
CN1259360A true CN1259360A (en) 2000-07-12
CN1123354C CN1123354C (en) 2003-10-08

Family

ID=5228352

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98123782A Expired - Fee Related CN1123354C (en) 1998-10-29 1998-10-29 Medicine for treating pulmonary hart diseases

Country Status (1)

Country Link
CN (1) CN1123354C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100490787C (en) * 2003-12-26 2009-05-27 王保安 Capsule for treating heart palpitation
CN104524535A (en) * 2015-01-15 2015-04-22 范丰双 Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition
CN105169061A (en) * 2015-10-09 2015-12-23 刘焰琼 Formula for treating excessive phlegm and yellow phlegm
CN105194166A (en) * 2015-11-08 2015-12-30 长沙佰顺生物科技有限公司 Medicine composition for treating heart diseases

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100490787C (en) * 2003-12-26 2009-05-27 王保安 Capsule for treating heart palpitation
CN104524535A (en) * 2015-01-15 2015-04-22 范丰双 Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition
CN104524535B (en) * 2015-01-15 2017-11-03 范丰双 It is a kind of to treat Chinese medicine composition of chronic cor pulmonale and preparation method thereof
CN105169061A (en) * 2015-10-09 2015-12-23 刘焰琼 Formula for treating excessive phlegm and yellow phlegm
CN105194166A (en) * 2015-11-08 2015-12-30 长沙佰顺生物科技有限公司 Medicine composition for treating heart diseases

Also Published As

Publication number Publication date
CN1123354C (en) 2003-10-08

Similar Documents

Publication Publication Date Title
CN111773308A (en) Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method
CN104587298A (en) Traditional Chinese medicinal composition for treating pulmonary abscess
CN1739611A (en) Stasis relieving oral liquid for treating rhinitis and its prepn
CN103463417B (en) Traditional Chinese medicine used for treating irritable bowel syndrome
CN1123354C (en) Medicine for treating pulmonary hart diseases
CN101953924A (en) Traditional Chinese medicine for treating chronic hepatitis
CN1097621A (en) Anti-cancer powder
CN1101199C (en) Chinese-medicinal capsule for treating hyperlipomia
CN1133458C (en) Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk
CN1055220C (en) Chinese drug for treatment of hemiplegia
CN102091165A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101953925A (en) Traditional Chinese medicine for treating chronic hepatitis
CN101940723A (en) Chinese medicinal preparation for treating pyelonephritis
CN101991685A (en) Traditional Chinese medicine for treating chronic hepatitis
CN1259090C (en) Oral liquid for treating common cold and coughing
CN102727765B (en) Internally-used medicine for treating aplastic anemia by nourishing yin and yang
CN102048930A (en) Formula of traditional Chinese medicine for treating chronic gastritis
CN1140284C (en) Chinese-medicinal pill for treating rheumatoid arthritis
CN113274470B (en) Traditional Chinese medicine composition for treating novel coronavirus pneumonia
CN102068533A (en) Traditional Chinese medicine for treating chronic hepatitis
CN1515284A (en) Rongshuan jiannaokang thrombolytic
CN1076622C (en) Chinese medicine for curing nephritis
CN105434634A (en) Traditional Chinese medicine composition for treating anemia
CN1056308C (en) Medicine for adjusting cranial nerve function
CN1049134C (en) Chinese prepared medicine for curing apoplexy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee